Crossmark

Efficacy of prophylactic antibiotics for the prevention of neutropenic fever in patients with multiple myeloma receiving high-dose cyclophosphamide for stem cell mobilization

Crossref DOI link: https://doi.org/10.1007/s00277-023-05537-3

Published Online: 2024-01-25

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hou, Li-qiong

Liu, Jun-Ru

Gu, Jing-Li

Chen, Mei-Lan

Kuang, Li-Fen

Huang, Bei-Hui

Zou, Wai-yi

Li, Juan https://orcid.org/0000-0002-0909-4731
License Information

Text and Data Mining valid from 2024-01-25

Version of Record valid from 2024-01-25
More Information

Article History

Received: 8 August 2023

Accepted: 2 November 2023

First Online: 25 January 2024

Declarations

:

: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).

: Informed consent was obtained from all patients for being included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below